Amazentis enters into strategic partnership with Nestlé Health Science

10. April 2019

Amazentis, an EPFL spin-off founded by Prof. Patrick Aebischer, has announced that it is entering into a strategic partnership with Nestlé Health Science.

Nestlé Health Science will take an equity stake in Amazentis and received global rights to use Amazentis’ patented Urolithin A, a promising anti-aging compound.

Kellerhals Carrard SA Lausanne/Sion (Jean-Luc Chenaux, partner, Stéphane Manaï, senior associate and Joséphine Marmy, associate) acted as legal advisor to Amazentis in this transaction. 

  1. Press Release (108 KB)